enGene Therapeutics ENGN
NASDAQ ENGN
$2.41 +0.13 (+5.70%)
At close: Nov 13, 2026 · 4:00 PM EST

enGene Therapeutics (ENGN) Other non-cash items (2023 - 2026)

Updated

Analysis

enGene Therapeutics (ENGN) Other non-cash items (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 enGene Therapeutics 161.50 Mn -832.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -42,000.00
Apr 30, 2026 -136,000.00
Jan 31, 2026 494,000.00
Oct 31, 2025 -69,000.00
Jul 31, 2025 202,000.00
Apr 30, 2025 54,000.00
Jan 31, 2025 292,000.00
Oct 31, 2024 159,000.00
Jul 31, 2024 165,000.00
Apr 30, 2024 110,000.00
Jan 31, 2024 569,000.00
Oct 31, 2023 44.43 Mn
Jul 31, 2023 -2.58 Mn
Apr 30, 2023 341,000.00
Jan 31, 2023 2.26 Mn
API Access

enGene Therapeutics Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=ENGN&period=max&api_key=YOUR_API_KEY